Kirby Institute
Kirby Institute
Explore linked clinical trials.19 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Better Options for Lymphatic Filariasis Treatment | Hemic and Lymphatic Diseases, Infections, Mosquito-Borne Diseases, Nematoda infectious disease, Rhabditida infectious disease, Secernentea Infections, Skin and Connective Tissue Diseases, Spirurida Infections, filarial elephantiasis, filariasis, helminthiasis, lymphatic system disorder, lymphedema, mite infestation, parasitic ectoparasitic infectious disease, parasitic infectious disease, parasitic skin disorder, scabies, skin disorder, skin disorder caused by infection, strongyloidiasis, vector-borne disease | Recruiting | Phase 3 | 2026-10-07 | NCT07159373 | |
| Optimised Dalbavancin Dosing for Serious Gram-Positive Bacterial Infections | Serious Gram-Positive Bacterial Infections | Not yet recruiting | Not stated | 2026-10-05 | NCT07858526 | |
| The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not stated | 2026-09-28 | NCT05713136 | |
| The National Australian HCV Point-of-Care Testing Program - Minimal Dataset | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not stated | 2026-09-28 | NCT05248555 | |
| The Australian HCV Point-of-Care Testing Program | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not stated | 2026-09-28 | NCT05042544 | |
| Swabs in Screening for HPV (SWISH) | Anal Cancer, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, anus disorder, anus neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm | Not yet recruiting | Not applicable | 2026-08-27 | NCT07790601 | |
| Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 4 | 2026-07-29 | NCT03855917 | |
| Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART) | Blood-Borne Infections, Body Weight, Body Weight Changes, Genital Diseases, HIV infectious disease, Infections, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Signs and Symptoms, Urogenital Diseases, Weight Gain, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 3 | 2026-07-22 | NCT06317051 | |
| Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study | Chemically-Induced Disorders, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 2 | 2026-06-26 | NCT07509112 | |
| Real World Assessment of People Living With Chronic Hepatitis B in Australia | Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not stated | 2026-05-19 | NCT04914611 | |
| ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not applicable | 2026-05-14 | NCT03685045 | |
| Combating Related Epidemics in HCV | AIDS, Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Flaviviridae infectious disease, Genital Diseases, HIV infectious disease, Hepadnaviridae infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, hepatitis, hepatitis B virus infection, hepatitis C virus infection, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, liver disorder, sexually transmitted disease, uterine carcinosarcoma, viral hepatitis, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 4 | 2026-05-05 | NCT07560046 | |
| Oritavancin for Treatment of Serious Cardiac Infections | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, cardiovascular disorder, endocarditis, gram-positive bacterial infections, heart disorder, infective endocarditis | Not yet recruiting | Phase 2 | 2026-04-29 | NCT07550595 | |
| Immunosuppression and COVID-19 Boosters | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 3 | 2026-02-24 | NCT05415267 | |
| Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons | Blood-Borne Infections, Digestive System Diseases, Flaviviridae infectious disease, Infections, RNA Virus Infections, hepatitis, hepatitis C virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Not applicable | 2025-12-29 | NCT07122219 | |
| Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases | Adenophorea Infections, Enoplea infectious disease, Hookworm Infections, Infections, Nematoda infectious disease, Secernentea Infections, Skin and Connective Tissue Diseases, Spirurida Infections, Strongylida infectious disease, filariasis, helminthiasis, mite infestation, onchocerciasis, parasitic ectoparasitic infectious disease, parasitic infectious disease, parasitic skin disorder, scabies, skin disorder, skin disorder caused by infection, trichuriasis | Recruiting | Phase 4 | 2025-11-21 | NCT07145736 | |
| Efficacy Study of 4CMenB (Bexsero®) to Prevent Gonorrhoea Infection in Gay and Bisexual Men | Bacterial Infections and Mycoses, Genital Diseases, Infections, Neisseriaceae Infections, Urogenital Diseases, bacterial infectious disease, bacterial sexually transmitted disease, gonorrhea, gram-negative bacterial infections, infectious disease, sexually transmitted disease | Active, not recruiting | Phase 3 | 2025-03-24 | NCT04415424 | |
| PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised. | Bacterial Infections and Mycoses, Infections, Invasive Fungal Infections, Soft Tissue Infections, bacterial infectious disease, fungal infectious disease | Not yet recruiting | Not stated | 2024-02-20 | NCT06220370 | |
| Age-related Clonal Haematopoiesis in an HIV Evaluation Cohort (ARCHIVE) | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Not stated | 2020-11-23 | NCT04641013 |